Get startedLog in
    Picture of SAMSUNG BIOLOGICS logo

    207940 — SAMSUNG BIOLOGICS News Story

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareBalancedLarge CapFalling Star
    All News

    Samsung Peptide to launch takeover bid for Swiss PolyPeptide

    Picture of SAMSUNG BIOLOGICS logoSAMSUNG BIOLOGICS
    31/08/2026 06:12
    Samsung Peptide to launch takeover bid for Swiss PolyPeptide
    Aug 31 (Reuters) - Samsung Peptide is launching a takeover offer for Swiss contract drugmaker PolyPeptide Group PPGN.S, the unit of Samsung Biologics 207940.KS said in an offer prospectus on Monday.
    It will offer 44.31 Swiss francs ($54.78) per registered PolyPeptide share, with the offer period set to run from September 15 to October 12.
    ($1 = 0.8089 Swiss francs)

    (Reporting by Tristan Veyet in Gdansk, editing by Milla Nissi-Prussak)
    ((Tristan.veyet@thomsonreuters.com;))

    Recent news on SAMSUNG BIOLOGICS

    See all news